While Amgen and Mirati are widely viewed as frontrunners to win the first front line approval, analysts—and competitors—say the field is still wide open.

Today the company said its experimental drug to treat major depressive disorder (MDD) had failed to significantly reduce the severity of the condition in a mid-stage study.

Daiichi Sankyo

The mRNA-based shot was initially approved as a booster in August, becoming Japan’s first home-grown shot for the coronavirus.

GSK logo

GSK said on that its blood cancer drug Blenrep had reached a key goal in a late-stage trial, as the British drugmaker looks to bolster its oncology business after a series of setbacks.

Sanofi

The company plans to seek U.S. approval for its best-selling anti-inflammatory drug Dupixent to be used in the treatment of “smoker’s lung”, also known as COPD, after a second large trial showed significant benefits.

artificial intelligence

As artificial intelligence (AI) continues to be adopted by the pharmaceutical industry, regulatory bodies in the United States and other countries are evolving to tackle challenges within the industry.

Neuralink

Four U.S. lawmakers have asked the Securities and Exchange Commission to investigate whether Elon Musk committed securities fraud by allegedly misleading investors about the safety of a brain implant being developed by the billionaire’s firm Neuralink, according to a letter to the regulator.

Chart growth, laptop

Analysts at GlobalData report that the oncology drug market is tilting toward biologics, and that the total market for these drugs will continue to grow rapidly, reaching $786 billion by 2029.

J&J, AbbVie, Genmab and Genentech are presenting new data at next month’s American Society of Hematology meeting on the therapeutic potential of their therapies in multiple myeloma and mantle cell lymphoma.

A batch of 331,200 doses of the vaccine – also known as RTS,S – was offloaded at Yaounde’s Nsimalen International Airport, making Cameroon the first African country to receive the vaccine after the pilot programs in Ghana, Kenya and Malawi.